GlobeNewswire

Lantronix Launches Advanced Wireless Embedded IoT Gateways

Dela

-- Compact xPico® 200 Gateways Deliver Versatile Connectivity and Intelligent Networking --

IRVINE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Lantronix, Inc. (NASDAQ:LTRX), a global provider of secure data access and management solutions for the industrial Internet of Things (IoT), today announced the launch of its xPico® 200 embedded IoT gateways. Measuring less than the size of a postage stamp, the compact xPico 200 embedded IoT gateways deliver robust Ethernet, Wi-Fi and Bluetooth connectivity, enterprise-grade security, and integrated manageability features that are ideal for industrial IoT applications.

A photo accompanying this announcement is available at 
http://www.globenewswire.com/NewsRoom/AttachmentNg/988d87cf-075e-4acf-90a1-27b42d595c46

"Today's advanced IoT applications require more than just simple connectivity," stated Shahram Mehraban, Lantronix vice president of marketing. "With the commercial launch of our xPico 200 product family, Lantronix is providing a robust compact solution that combines best-in-class wired and wireless connectivity, industrial grade design and intelligent networking that enables resource-constrained product development teams to reduce total cost of ownership and time to market for their industrial IoT solutions."

"With its state-of-the-art fast roaming capabilities and integrated manageability, the xPico 200 embedded gateways deliver reliable functionality and performance that will enable us to efficiently develop very cost competitive connected products," said Paul Blashewski, president of Prescient Wireless.

Combining the Lantronix intelligent networking communications engine with Cypress Semiconductor's industry-leading wireless SoC, the xPico 200 gateways deliver best-in-class managed industrial Wi-Fi connectivity that enables industrial OEMs to simplify and accelerate development of their smart connected solutions. Currently, the xPico 200 gateways are being designed into industrial, medical, retail, smart building and transportation verticals.

"Lantronix has developed an industry-leading secure embedded solution that enables OEMs to utilize the Cypress CYW43907 802.11n Wi-Fi MCU to provide network reliability and flexibility to do more," said Andrew Hunter, senior director of marketing at Cypress Semiconductor. "The xPico 200 series represents another milestone in our collaboration with Lantronix and addresses the growing need for industrial IoT solutions that deliver robust connectivity, processing capabilities and manageability."

The xPico 200 product family features include:

  • Highly integrated industrial grade Wi-Fi and versatile connectivity
    ° 
    Seamlessly integrated Wi-Fi, Ethernet and Bluetooth (BT and BLE) connectivity - no need to write complex drivers
    ° Dual-band 802.11a/b/g/n Wi-Fi delivers higher performance and reliability, minimizing interference
    ° Industrial grade design supporting long life and reliable operation in extreme environments
    ° Lantronix concurrent Soft AP + Client that provides device support and access without disrupting machine field operations
     
  • Robust data access and management
    ° 
    Intelligent networking and automatic connection management
    ° Field-tested TruPort® Serial and TruPort® Socket enable out-of-the-box connectivity locally and over the Internet for hundreds of serial machine protocols
    ° Built-in network communications engine simplifies embedded application development
    ° Pre-integrated with Lantronix MACH10(TM) IoT platform, including MACH10 Global Device Manager
     
  • Built-in comprehensive device security services
    ° 
    Enterprise-grade TruPort® Security ensure security of both data-at-rest and data-in-motion
    ° Secure connectivity to WPA2-Enterprise Wi-Fi networks
    ° Secure boot and secure FOTA (firmware over the air) features allow only authorized software to run on the gateway             

The xPico 240 is available through the worldwide network of authorized Lantronix distributors and resellers. xPico 250 evaluation kits will be available this month with product availability in early 2018. For more information about the xPico 200 product family, go to www.lantronix.com/xpico-200 or contact a local Lantronix sales office.

About Lantronix  
Lantronix, Inc. is a global provider of secure data access and management solutions for Internet of Things (IoT) assets. Our mission is to be the leading supplier of IoT solutions that enable companies to dramatically simplify the creation, deployment, and management of IoT projects while providing secure access to data for applications and people.

With more than two decades of experience in creating robust machine to machine (M2M) technologies, Lantronix is an innovator in enabling our customers to build new business models and realize the possibilities of the Internet of Things. Our connectivity solutions are deployed inside millions of machines serving a wide range of industries, including industrial, medical, security, transportation, retail, financial, environmental and government.

Lantronix is headquartered in Irvine, California. For more information, visit www.lantronix.com.

Learn more at the Lantronix blog, www.lantronix.com/blog, featuring industry discussion and updates. To follow Lantronix on Twitter, please visit www.twitter.com/Lantronix. View our video library on YouTube at www.youtube.com/user/LantronixInc or connect with us on LinkedIn at www.linkedin.com/company/lantronix.

Lantronix Media and Analyst Contact:  
E.E. Wang
Director, Corporate Marketing and Investor Relations
media@lantronix.com
investors@lantronix.com 
949-614-5879

Lantronix Sales: 
sales@lantronix.com
Americas +1 (800) 422-7055 (US and Canada) or +1 949-453-3990
Europe, Middle East and Africa +31 (0)76 52 36 744
Asia Pacific + 852 3428-2338
China + 86 21-6237-8868
Japan +81 (0) 50-1354-6201
India +91 994-551-2488

© 2017 Lantronix, Inc. All rights reserved. Lantronix, TruPort and xPico are registered trademarks, and MACH10 is a trademark, of Lantronix Inc. Wi-Fi is a registered trademark of Wi-Fi Alliance. The Bluetooth word mark and Bluetooth Smart Ready are registered trademarks owned by the Bluetooth SIG, Inc. Other trademarks and trade names are those of their respective owners.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lantronix Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Corline Biomedical AB: Patientrekrytering startar i Renaparin-studie30.11.2018 16:37Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att patientrekrytering i den kliniska fas 1-studien RENAPAIR-01 startar. I studien utvärderas bolagets läkemedelskandidat Renaparin® som är under utveckling för att förbättra utfallet av njurtransplantation. Patienter kommer inledningsvis att rekryteras på Akademiska sjukhuset i Uppsala. När de fyra första patienterna utvärderats inleds också rekrytering på Karolinska Universitetssjukhuset i Huddinge. Beskedet att patientrekrytering startar innebär att förberedelsearbetet inför studiestart är avslutat och att till exempel avtal, initieringsmöte, logistik, provhantering och monitorering är hanterat, samt att godkänt prövningsläkemedel nu finns tillgängligt för rekvirering av kirurgerna på transplantationskliniken i Uppsala för dosering till donatornjurar. När första patient doserats kommer detta meddelas separat. Corline har utvecklat och äger rättigheterna till Renaparin® som administreras direkt till den donerade njuren i

Stillfront: Bytro Labs lanserar en ny version av Supremacy 191427.11.2018 08:00Pressmeddelande

PRESSMEDDELANDE 2018-11-27 Bytro Labs, en studio inom Stillfront Group, lanserar en ny version av Supremacy 1914 Spelutvecklaren Bytro Labs, mest kända för sitt framgångsrika strategispel Call of War, har släppt en ny version av sin klassiska speltitel Supremacy 1914. Dagens lansering är den första av tre milstolpar för den nya versionen av Supremacy 1914 - The Great War som släpps 2019. Den första uppdateringen innehåller en komplett omarbetning av området för spelets community, ett nytt utseende för kartan samt ny 3D-teknologi. I nästa steg kommer Bytro Labs att gå vidare till "true cross platform" där spelet tillgängliggörs för fler plattformar, en strategi som tidigare har varit framgångsrik för titeln Call of War. Supremacy 1914 - The Great War släpps för Android senare i år och i början av 2019 släpps spelet för iOS och Steam. Det tredje och sista steget i lanseringen kommer i mitten av 2019 innehållande en större uppdatering avseende både innehåll och funktion, som färdigställer

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum